IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO

Stock Information for Imunon Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Imunon Inc.

Abstract on Phase 2 Study with IMUNON's IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting
IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study
IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024
IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101
IMUNON Reports Compliance with Nasdaq Listing Requirements
IMUNON Reports 2023 Financial Results and Provides Business Update
IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.